483 Zhejiang Jingxin Pharmaceutical Nov 2018

483 Zhejiang Jingxin Pharmaceutical Nov 2018

$119 - Not in Stock

FDA investigators audited the Zhejiang Jingxin Pharmaceutical - Shaoxing, China facility and issued inspectional observations (via FDA 483) on 09 Nov 2018.

Product details

  • Category: Human Drugs
  • Inspection end: 09 Nov 2018
  • Location: Shaoxing, China
  • FEI: 2000033505

Pre-Order Not Available